π About
- Eosinophilic Oesophagitis (EoE) = chronic, immune-mediated inflammation of the oesophagus.
- First recognised as a distinct disease in the 1990s.
- Food antigens (π₯ milk, πΎ wheat, π³ eggs, π seafood, π± soy) strongly implicated.
- Pathology = infiltration of eosinophils β mucosal inflammation β fibrosis β stricturing.
π Incidence
- Predominantly affects white men aged 30β50.
- Estimated incidence β 7 per 100,000 per year (rising with improved recognition).
𧬠Aetiology & Pathophysiology
- Genetics: Variants in CAPN14 and TSLP (thymic stromal lymphopoietin) genes increase susceptibility.
- Barrier dysfunction: Loss of anti-proteases β increased epithelial permeability β allergen penetration.
- Immune signalling: β eotaxin-3 expression β recruitment of eosinophils β chronic inflammation.
- Result = mucosal fibrosis, trachealisation of oesophagus, stricture formation.
π§Ύ Diagnostic Criteria
- Symptoms of oesophageal dysfunction (e.g. dysphagia, food bolus impaction).
- > 15 eosinophils / high power field on oesophageal biopsy π¬.
- Persistent eosinophilia despite 8-week PPI trial π.
- Exclusion of secondary causes of eosinophilia (see below).
π©Ί Clinical Features
- Dysphagia (solids > liquids) ππ₯©
- Food bolus impaction π (often requiring A&E attendance)
- Chest pain or reflux-like symptoms despite PPI use
- Narrow-calibre oesophagus β slow eating, avoidance of hard textures
- Children may present with feeding difficulties, failure to thrive
π¬ Investigations
- Endoscopy (OGD):
- Rings (βtrachealisationβ of oesophagus) π
- Linear furrows π
- White exudates βοΈ
- Friability, mucosal oedema, loss of vascular pattern
- Fixed strictures in advanced disease
- Biopsy: > 15 eosinophils/hpf confirms diagnosis (after PPI trial).
- Bloods: May show peripheral eosinophilia, but not diagnostic.
π Causes of Oesophageal Eosinophilia
- Eosinophilic oesophagitis β
- GORD (reflux disease)
- PPI-responsive oesophageal eosinophilia
- Achalasia
- Crohnβs disease
- Parasitic infection πͺ±
- Drug hypersensitivity π
- Connective tissue disease (e.g. scleroderma, dermatomyositis)
- Coeliac disease πΎ
- Hypereosinophilic syndrome
π‘ Exam tip: A PPI trial (8 weeks) is essential before diagnosing EoE to exclude GORD.
π Management
- Dietary modification:
- Empirical elimination diet (milk, wheat, eggs, soy, seafood) ππ₯π³
- Elemental diet in severe cases
- Consider formal allergy testing
- Pharmacological:
- High-dose PPI (also helps differentiate from GORD)
- Topical swallowed steroids (fluticasone, budesonide via inhaler MDI without spacer) β reduce inflammation
- Course: typically 8 weeks, then re-scope
- Endoscopic intervention:
- Dilatation for strictures π
- Reserved for refractory or critically narrowed oesophagus
π References